LSA
TAK icon

Leonteq Securities AG’s Takeda Pharmaceutical TAK Stock Holding History

Leonteq Securities AG’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,000
Closed -$104K – 1354
2022
Q3 		$104K Hold
8,000
– – ﹤0.01% 635
2022
Q2 		$112K Hold
8,000
– – ﹤0.01% 660
2022
Q1 		$115K Sell
8,000
-3,780
-32% -$55.5K ﹤0.01% 704
2021
Q4 		$161K Buy
11,780
+8,000
+212% +$112K 0.01% 675
2021
Q3 		$61.9K Hold
3,780
– – ﹤0.01% 811
2021
Q2 		$63.6K Hold
3,780
– – ﹤0.01% 802
2021
Q1 		$69K Hold
3,780
– – ﹤0.01% 749
2020
Q4 		$68.8K Buy
+3,780
New +$66.3K ﹤0.01% 734

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return